Open AccessPrognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study
Author(s) -
Dong Hoon Lee,
Jae Yong Jeong,
Wan Song
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s291327
Subject(s) - cystectomy , medicine , bladder cancer , hazard ratio , oncology , proportional hazards model , immunohistochemistry , cisplatin , chemotherapy , cohort , retrospective cohort study , immunotherapy , survival analysis , cancer , urology , confidence interval
To investigate the prognostic value of programmed death ligand-1 (PD-L1) expression in tumor-infiltrating immune cells (ICs) in men treated with adjuvant chemotherapy (AC) following radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC).